Browse Category

Stock Market News 23 January 2026

CRISPR Therapeutics stock in focus as shares cool premarket after 11% surge and CEO sale filing

CRISPR Therapeutics stock in focus as shares cool premarket after 11% surge and CEO sale filing

CRISPR Therapeutics shares slipped 0.5% to $60.51 in premarket trading Friday after CEO Samarth Kulkarni sold 90,000 shares for about $5.2 million under a preset plan, an SEC filing showed. The stock had surged 11.1% Thursday on heavy volume. Options trading spiked, with focus on April $90 calls. Bank of America trimmed its price target to $89 but kept a Buy rating.
Atul Q3 results: profit jumps 40% but labour-code costs bite; shares end higher

Atul Q3 results: profit jumps 40% but labour-code costs bite; shares end higher

Atul Ltd shares rose 1.03% to 5,833.25 rupees after reporting a 40% year-on-year profit jump to 163.54 crore rupees for the December quarter, with revenue up 11% to 1,573.62 crore. Operating expenses climbed 2.9% from the previous quarter, and employee benefit costs surged due to a 41.35 crore rupee provision for new labour codes. Indian stocks closed lower, with the Nifty 50 down 0.95%.
CSGS stock price inches from NEC’s $80.70 deal — what traders watch before the Jan. 30 vote

CSGS stock price inches from NEC’s $80.70 deal — what traders watch before the Jan. 30 vote

CSG Systems closed Thursday at $79.83, just below NEC’s $80.70-per-share cash offer ahead of a Jan. 30 shareholder vote on the deal. The stock hit a 52-week high of $80.28 during the session. SEC filings show CEO Brian Shepherd and CFO Hai Tran received restricted stock grants dated Jan. 20. NEC’s $2.89 billion acquisition awaits shareholder and regulatory approval.
23 January 2026
Record defence IPO: Czech arms group CSG jumps as much as 32% in Amsterdam debut

Record defence IPO: Czech arms group CSG jumps as much as 32% in Amsterdam debut

Czechoslovak Group (CSG) shares jumped as much as 32% in their Amsterdam debut after pricing at 25 euros, following a record 3.3 billion euro IPO. The offering valued CSG at 25 billion euros and could reach 3.8 billion euros if the over-allotment is used. By 0812 GMT, shares traded at 30.235 euros, up 20.9%. BlackRock, Artisan Partners, and Al-Rayyan Holdings each committed 300 million euros as cornerstone investors.
Direct Digital Holdings stock price jumps 71% in premarket as DRCT rally puts Nasdaq deadline back in focus

Direct Digital Holdings stock price jumps 71% in premarket as DRCT rally puts Nasdaq deadline back in focus

Direct Digital Holdings shares jumped 71% to $3.95 in premarket trading Friday after a 30% gain Thursday. The surge follows a 55-for-1 reverse stock split that cut the Class A share count to about 1.3 million. Nasdaq’s Jan. 30 deadline for the $1 minimum bid price rule still threatens delisting. Trading volume Thursday reached nearly 12 million shares.
23 January 2026
Regencell Bioscience stock price jumps again: RGC up 16% premarket after 40% surge

Regencell Bioscience stock price jumps again: RGC up 16% premarket after 40% surge

Regencell Bioscience shares jumped 16.3% to $35.77 in premarket trading Friday after a 40.4% surge Thursday, with no new company announcements. Thursday’s rally saw heavy volume and wide price swings, closing at $30.77. The company’s filings warn of “extreme price and volume fluctuations” and note it has no saleable products or revenue. Market cap reached about $15.2 billion as of Friday.
Novo Nordisk stock price jumps before the bell as Wegovy pill prescriptions leap

Novo Nordisk stock price jumps before the bell as Wegovy pill prescriptions leap

Novo Nordisk shares rose 4.9% to $62.23 in premarket trading after new data showed U.S. prescriptions for the oral Wegovy pill jumped to 20,392 from 4,286. The surge comes as investors watch prescription trends ahead of Novo’s Feb. 4 results. Rival Eli Lilly shares edged up 0.8%. India’s Sun Pharmaceutical won approval to produce generic semaglutide after the patent expires in March.
23 January 2026
Intuitive Surgical stock jumps premarket after earnings beat, but 2026 tariff hit gets attention

Intuitive Surgical stock jumps premarket after earnings beat, but 2026 tariff hit gets attention

Intuitive Surgical shares jumped 3.6% premarket to $545 after beating fourth-quarter estimates and reporting an 18% rise in global procedures. The company forecast slower 2026 procedure growth of 13%–15% and said tariffs would cut margins by about 1.2% of revenue. Traders are watching for analyst updates at the open. Cash and investments totaled $9.03 billion at year-end.
Datavault AI stock jumps again in premarket after 20% surge; DVLT back near $1

Datavault AI stock jumps again in premarket after 20% surge; DVLT back near $1

Datavault AI Inc shares rose 7.8% to $0.967 in Friday premarket trading after a 20.2% jump Thursday, with no new company news since mid-January. The company recently filed to register 7.5 million shares for intellectual property rights and plans to distribute warrants on Feb. 21. Trading volume Thursday reached about 94 million shares. Traders are watching if the premarket surge holds once regular trading begins.
23 January 2026
Intel stock slumps 14% in premarket after weak forecast flags AI server-chip pinch

Intel stock slumps 14% in premarket after weak forecast flags AI server-chip pinch

Intel shares fell 14% to $46.69 premarket Friday after warning first-quarter results will miss forecasts due to supply constraints. The company reported Q4 revenue down 4% to $13.7 billion and a GAAP loss of 12 cents per share. Intel expects Q1 revenue between $11.7 billion and $12.7 billion, below analyst estimates. Options trading surged ahead of the drop, with heavy activity in $50 strike puts.
Abbott stock sank 10% on earnings — what traders watch before the bell

Abbott stock sank 10% on earnings — what traders watch before the bell

Abbott shares hovered near $109 in early premarket Friday after a 10% post-earnings drop, following a fourth-quarter revenue miss driven by weakness in nutrition and diagnostics. Nutrition sales fell 8.9% to $1.94 billion, while medical-device sales rose 12.3%. The company forecast first-quarter adjusted earnings of $1.12 to $1.18 per share and expects to close its Exact Sciences acquisition in Q2.
Antofagasta share price slips in London as Twin Metals vote and copper swings keep traders cautious

Antofagasta share price slips in London as Twin Metals vote and copper swings keep traders cautious

Antofagasta plc shares fell 0.6% to 3,495 pence in early London trading. The U.S. House voted 214-208 to overturn Minnesota’s mining ban, potentially reviving Antofagasta’s Twin Metals project if the Senate agrees. Copper prices rose 0.4% after recent volatility, with analysts citing tight supply and weak Chinese demand. Investors await Antofagasta’s quarterly update on Jan. 29.

Stock Market Today

Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

8 February 2026
Tower Semiconductor shares rose 7.7% to $139.04 Friday after announcing a collaboration with Nvidia on AI data-center networking. The stock touched $141 intraday and gained another 1% after hours. Investors await Tower’s Feb. 11 earnings for details on its silicon photonics work. No financial terms or shipment timeline were disclosed.
Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

8 February 2026
Longsys disclosed new guarantees for a 100 million yuan Hong Kong loan and a $9 million Brazil credit line, bringing its total approved guarantee quota to 11 billion yuan and outstanding guarantees to 5.81 billion yuan. The company said all guarantees are for consolidated subsidiaries and within approved limits. Shares closed at 288 yuan Friday, down 1.6%. China inflation and credit data are due this week.
MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

8 February 2026
MACOM shares rose 3.5% to $235.87 Friday after the company reported fiscal Q1 revenue of $271.6 million and raised its full-year data center growth outlook to 35–40%. Fidelity’s FMR LLC disclosed a 10.7% stake, while shareholder Susan Ocampo filed to potentially sell up to 100,000 shares. Stifel raised its price target to $255. MACOM expects to repay $161 million in convertible notes in March.
Go toTop